Aarti Pharmalabs Ltd

Aarti Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aarti Pharmalabs Ltd

₹ 364 -0.71%
02 Jun - close price
aartipharmalabs.com BSE: 543748 NSE : AARTIPHARM
About

Aarti Pharmalabs Limited manufactures Active Pharmaceutical Ingredients (API) and New Chemical Entities (NCE), API intermediates, Regulatory Starting Materials (RSM), Basic Starting Materials, Key Building Blocks, and Xanthine Derivatives for use in clinical testing and for commercial production.[1]

[ add key points ]
Website BSE NSE
  • Market Cap ₹ 3,299 Cr.
  • Current Price ₹ 364
  • High / Low ₹ 422 / 235
  • Stock P/E 17.0
  • Book Value ₹ 172
  • Dividend Yield 0.00 %
  • ROCE 16.1 %
  • ROE 13.1 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company's working capital requirements have reduced from 177 days to 141 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Dec 2022 Mar 2023
460 472 485
385 385 405
Operating Profit 76 86 80
OPM % 16% 18% 16%
3 0 1
Interest 5 5 6
Depreciation 14 16 16
Profit before tax 59 65 59
Tax % 18% 27% 27%
Net Profit 49 48 43
EPS in Rs 5.26 4.73
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
0 1,200 1,945
0 993 1,603
Operating Profit 0 207 342
OPM % 17% 18%
0 3 2
Interest 0 12 21
Depreciation 0 42 63
Profit before tax 0 155 261
Tax % 21% 26%
Net Profit 0 122 193
EPS in Rs 21.35
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 62%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 58%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
0 0 45
Reserves -0 1,386 1,513
0 338 214
0 315 458
Total Liabilities 0 2,040 2,231
0 782 966
CWIP 0 187 62
Investments 0 32 74
0 1,038 1,130
Total Assets 0 2,040 2,231

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
0 -44 263
0 -139 -158
0 260 -163
Net Cash Flow 0 78 -58

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
Debtor Days 115 83
Inventory Days 272 188
Days Payable 123 108
Cash Conversion Cycle 264 162
Working Capital Days 214 141
ROCE % 19% 16%

Shareholding Pattern

Numbers in percentages

Mar 2023
45.98
7.69
13.68
0.01
32.64

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

Credit ratings